Differentiation of 3-O-Sulfated Heparin Disaccharide Isomers: Identification of Structural Aspects of the Heparin CCL2 Binding Motif

Journal of the American Society for Mass Spectrometry

Volumn 20, Issue 4, 2009, Pages 652-657

  Meissen, John K ^a   Sweeney, Matthew D ^a,b   Girardi, Matthew ^a,c   Lawrence, Roger ^d   Esko, Jeffrey D ^d   Leary, Julie A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Novozymes Biotech Inc   (United States)

^c University of California   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BINDING MOTIFS; CHEMOKINE; GLUCOSAMINE; HEPARAN SULFATES; HEPARIN DISACCHARIDES; HIGH AFFINITIES; OCTASACCHARIDE; STRUCTURAL ASPECTS; SULFATE GROUPS; TANDEM MASS SPECTROMETRIES;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOMERS; MASS SPECTROMETRY;

POLYSACCHARIDES;

ANIMALS; BINDING SITES; CHEMOKINE CCL2; CHO CELLS; CRICETINAE; CRICETULUS; DISACCHARIDES; GLYCOSAMINOGLYCANS; HEPARIN; HUMANS; ISOMERISM; OLIGOSACCHARIDES; PROTEIN BINDING; SULFATES; TANDEM MASS SPECTROMETRY;

SIMPLEXVIRUS;

EID: 62149152738     PISSN: 10440305     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jasms.2008.12.002     Document Type: Article

References (33)

1. Chen Y., Maguire T., Hileman R.E., Fromm J.R., Esko J.D., Linhardt R.J., and Marks R.M. Dengue Virus Infectivity Depends on Envelope Protein Binding to Target Cell Heparan Sulfate. Nat. Med. 3 (1997) 866-871
2. Shukla D., Liu J., Blaiklock P., Shworak N.W., Bai X., Esko J.D., Cohen G.H., Eisenberg R.J., Rosenberg R.D., and Spear P.G. A Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry. Cell 99 (1999) 13-22
3. Castellot J.J., Hoover R.L., Harper P.A., and Karnovsky M.J. Heparin and Glomerular Epithelial Cell-Secreted Heparin-Like Species Inhibit Mesangial-Cell Proliferation. Am. J. Pathol. 120 (1985) 427-435
4. Perrimon N., and Bernfield M. Specificities of Heparan Sulphate Proteoglycans in Developmental Processes. Nature 404 (2000) 725-728
5. Marcum J.A., McKenney J.B., Galli S.J., Jackman R.W., and Rosenberg R.D. Anticoagulantly Active Heparin-Like Molecules from Mast Cell-Deficient Mice. Am. J. Physio. 250 (1986) H879-H888
6. Vlodavsky I., Friedmann Y., Elkin M., Aingorn H., Atzmon R., Ishai-Michaeli R., Bitan M., Pappo O., Peretz T., Michal I., Spector L., and Pecker I. Mammalian Heparanase: Gene Cloning, Expression, and Function in Tumor Progression and Metastasis. Nat. Med. 5 (1999) 793-802
7. Hulett M.D., Freeman C., Hamdorf B.J., Baker R.T., Harris M.J., and Parish C.R. Cloning of Mammalian Heparanase, an Important Enzyme in Tumor Invasion and Metastasis. Nat. Med. 5 (1999) 803-809
8. Rabenstein D.L. Heparin and Heparan Sulfate: Structure and Function. Nat. Prod. Reports 19 (2002) 312-331
9. Bishop J.R., Schuksz M., and Esko J.D. Heparan Sulphate Proteoglycans Fine-Tune Mammalian Physiology. Nature 446 (2007) 1030-1037
10. Esko J.D., and Selleck S.B. Order out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate. Annu. Rev. Biochem. 71 (2002) 435-471
11. Conrad H.E. Heparin-Binding Proteins (1998), Academic Press, San Diego, CA pp. 1-5 183-202
12. Lindahl U., Kusche-Gullberg M., and Kjellén L. Regulated Diversity of Heparan Sulfate. J. Biol. Chem. 273 (1998) 24979-24982
13. Atha D.H., Lormeau J.C., Petitou M., Rosenberg R.D., and Choay J. Contribution of Monosaccharide Residues in Heparin Binding to Antithrombin Iii. Biochemistry 24 (1985) 6723-6729
14. de Kort M., Buijsman R.C., and van Boeckel C.A. Synthetic Heparin Derivatives as New Anticoagulant Drugs. Drug Discov. Today 10 (2005) 769-779
15. Petitou M., Casu B., and Lindahl U. 1976-1983, a Critical Period in the History of Heparin: The Discovery of the Antithrombin Binding Site. Biochimie 85 (2003) 83-89
16. Tiwari V., Clement C., Xu D., Valyi-Nagy T., Yue B.Y., Liu J., and Shukla D. Role for 3-O-Sulfated Heparan Sulfate as the Receptor for Herpes Simplex Virus Type 1 Entry into Primary Human Corneal Fibroblasts. J. Virol. 80 (2006) 8970-8980
17. Chen J., and Liu J. Characterization of the Structure of Antithrombin-Binding Heparan Sulfate Generated by Heparan Sulfate 3-O-Sulfotransferase 5. Biochim. Biophys. Acta 1725 (2005) 190-200
18. Liu J., Shriver Z., Blaiklock P., Yoshida K., Sasisekharan R., and Rosenberg R.D. Heparan Sulfate D-Glucosaminyl 3-O-Sulfotransferase-3a Sulfates N-Unsubstituted Glucosamine Residues. J. Biol. Chem. 274 (1999) 38155-38162
19. Venkataraman G., Shriver Z., Raman R., and Sasisekharan R. Sequencing Complex Polysaccharides. Science 286 (1999) 537-542
20. Saad O.M., and Leary J.A. Compositional Analysis and Quantification of Heparin and Heparan Sulfate by Electrospray Ionization Ion Trap Mass Spectrometry. Anal. Chem. 75 (2003) 2985-2995
21. Saad O.M., Ebel H., Uchimura K., Rosen S.D., Bertozzi C.R., and Leary J.A. Compositional Profiling of Heparin/Heparan Sulfate Using Mass Spectrometry: Assay for Specificity of a Novel Extracellular Human Endosulfatase. Glycobiology 15 (2005) 818-826
22. Rossi D., and Zlotnik A. The Biology of Chemokines and Their Receptors. Ann. Rev. Immunol. 18 (2000) 217-242
23. Proudfoot A.E., Handel T.M., Johnson Z., Lau E.K., LiWang P., Clark-Lewis I., Borlat F., Wells T.N., and Kosco-Vilbois M.H. Glycosaminoglycan Binding and Oligomerization are Essential for the In Vivo Activity of Certain Chemokines. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 1885-1890
24. Johnson Z., Kosco-Vilbois M.H., Herren S., Cirillo R., Muzio V., Zaratin P., Carbonatto M., Mack M., Smailbegovic A., Rose M., Lever R., Page C., Wells T.N., and Proudfoot A.E. Interference with Heparin Binding and Oligomerization Creates a Novel Anti-Inflammatory Strategy Targeting the Chemokine System. J. Immunol. 137 (2004) 5776-5785
25. Yu Y., Sweeney M.D., Saad O.M., Crown S.E., Hsu A.R., Handel T.M., and Leary J.A. Chemokine-Glycosaminoglycan Binding: Specificity for Ccr2 Ligand Binding to Highly Sulfated Oligosaccharides Using FTICR Mass Spectrometry. J. Biol. Chem. 280 (2005) 32200-32208
26. Desai U.R., Wang H.M., and Linhardt R.J. Specificity Studies on the Heparin Lyases from Flavobacterium Heparinum. Biochemistry 32 (1993) 8140-8145
27. Lawrence R., Kuberan B., Lech M., Beeler D.L., and Rosenberg R.D. Mapping Critical Biological Motifs and Biosynthetic Pathways of Heparan Sulfate. Glycobiology 14 (2004) 467-479
28. Lawrence R., Lu H., Rosenberg R.D., Esko J.D., and Zhang L. Disaccharide Structure Code for the Easy Representation of Constituent Oligosaccharides from Glycosaminoglycans. Nat. Methods 5 (2008) 291-292
29. Sweeney M.D., Yu Y., and Leary J.A. Effects of Sulfate Position on Heparin Octasaccharide Binding to Ccl2 Examined by Tandem Mass Spectrometry. J. Am. Soc. Mass Spectrom. 17 (2006) 1114-1119
30. Paavola C.D., Hemmerich S., Grunberger D., Polsky I., Bloom A., Freedman R., Mulkins M., Bhakta S., McCarley D., Wiesent L., Wong B., Jarnagin K., and Handel T.M. Monomeric Monocyte Chemoattractant Protein-1 (Mcp-1) Binds and Activates the Mcp-1 Receptor Ccr2b. J. Biol. Chem. 273 (1998) 33157-33165
31. Domon B., and Costello C.E. A Systematic Nomenclature for Carbohydrate Fragmentations in Fab-MS/MS Spectra of Glycoconjugates. Glycoconjugate J. 5 (1988) 397-409
32. Staempfli A., Zhou Z., and Leary J.A. Gas-Phase Dissociation Mechanisms of Dilithiated Disaccharides: Tandem Mass Spectrometry and Semiempirical Calculations. J. Org. Chem. 57 (1992) 3590-3594
33. Leary J.A., Zhou Z., Ogden S., and Williams T.D. Gas Phase Investigation of Lithiated Peptide Adducts: Tandem Mass Spectrometry and Semiempirical Studies. J. Am. Soc. Mass Spectrom. 1 (1990) 473-480